NasdaqGS - Delayed Quote USD

Canopy Growth Corporation (CGC)

9.86 +0.83 (+9.19%)
At close: May 9 at 4:00 PM EDT
10.09 +0.23 (+2.33%)
Pre-Market: 7:40 AM EDT
Loading Chart for CGC
DELL
  • Previous Close 9.03
  • Open 9.01
  • Bid 9.85 x 6600
  • Ask 9.94 x 5900
  • Day's Range 8.76 - 10.18
  • 52 Week Range 2.76 - 19.20
  • Volume 17,255,851
  • Avg. Volume 15,562,432
  • Market Cap (intraday) 740.012M
  • Beta (5Y Monthly) 1.85
  • PE Ratio (TTM) --
  • EPS (TTM) -15.51
  • Earnings Date Jun 20, 2024 - Jun 24, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.40

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

www.canopygrowth.com

1,621

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CGC

Performance Overview: CGC

Trailing total returns as of 5/9/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CGC
92.95%
S&P/TSX Composite index
6.76%

1-Year Return

CGC
25.30%
S&P/TSX Composite index
8.70%

3-Year Return

CGC
96.10%
S&P/TSX Composite index
14.91%

5-Year Return

CGC
97.95%
S&P/TSX Composite index
36.46%

Compare To: CGC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CGC

Valuation Measures

Annual
As of 5/8/2024
  • Market Cap

    676.51M

  • Enterprise Value

    1.05B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.21

  • Price/Book (mrq)

    1.70

  • Enterprise Value/Revenue

    2.89

  • Enterprise Value/EBITDA

    -1.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -8.89%

  • Return on Equity (ttm)

    -121.56%

  • Revenue (ttm)

    362.24M

  • Net Income Avi to Common (ttm)

    -1.18B

  • Diluted EPS (ttm)

    -15.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    188.38M

  • Total Debt/Equity (mrq)

    127.28%

  • Levered Free Cash Flow (ttm)

    -95.08M

Research Analysis: CGC

Analyst Price Targets

3.00 Low
4.40 Average
9.86 Current
5.19
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CGC

Research Reports: CGC

  • Cannabis Shares Rally (Again) on Next Incremental Step to Federal Rescheduling

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     
  • First Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     
  • Canopy's Financial Performance Improving, but Repeated Dilution Continues to Destroy Value

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     
  • Canopy's Financial Performance Improving, but Repeated Dilution Continues to Destroy Value

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

    Rating
    Price Target
     

People Also Watch